I. Nanjing Xinbai 600682
In terms of return on net assets, from 20 17 to 2020, it will be 10.4 1%, -6.74%,1.76% and 4.74% respectively. The company initiated the establishment of Xinbai Innovation Health Investment Fund and other projects, trying to lay out the medical and health industry, exploring medical and old-age care services, developing the mode of combining medical care with nursing care and providing for the elderly at home in the community, and further creating a new profit model, making it a new growth point of the company's performance.
Second, Yun Sheng Medical 600767
In terms of return on net assets, from 20 17 to 2020, it will be 17.7 1%, 7.38%, -28.04% and 4.4% respectively. Cooperate with Zhongyu Capital, a well-known medical and health equity investment institution, to set up an M&A investment fund for medical and health industry, mainly targeting smart medical care, wearable devices, mobile medical care and Internet health; The fund raised is 437 million yuan, which is intended to be used for the construction and operation of the Internet health ecosystem.
Three. Vanke A000002
In terms of return on net assets, from 20 17 to 2020, it will be 22.8%, 23.24%, 22.47% and 20. 13% respectively. In the future, the fund will invest in industrial projects including but not limited to medical services, and CITIC Capital is the managing partner of the fund.
4. Neusoft Group 6007 18
In terms of return on net assets, from 20 17 to 2020, it will be 12.78%, 1.22%, 0.43% and 1.57% respectively. The company said that this strategic cooperation with Nokia Bell will be based on the world's leading 5G end-to-end commercial products and solutions owned by Nokia Bell, combined with the company's technical advantages and experience in the fields of medical health cloud, smart car networking and smart city, and fully release Neusoft's accumulation in the fields of mobile Internet, Internet of Things, cloud computing and big data.
Verb (abbreviation of verb) Wantong Development 600246
In terms of return on net assets, from 20 17 to 2020, it will be 5.26%, 4.64%, 8. 1 1% and 0.66% respectively. Actively explore a new mode of transformation and upgrading of the real estate industry that combines high-tech, service industry and real estate, and gain some experience. The company has also conducted in-depth research or layout in the fields of new energy, new materials, energy conservation and environmental protection, medical care, sports, exhibitions and so on around the direction of combining real estate with high technology and services. Through the strategic cooperation with Zhongrong International Trust, Wantong Real Estate will accelerate the transformation and upgrading of its real estate business to the tertiary industry with real estate financial services as the mainstay on the basis of past experience.
VI. Xianghai Pharmaceutical 002099
In terms of return on net assets, from 20 17 to 2020, it will be 6.9%, 1 1.35%, 14.07% and 5.79% respectively. The company adheres to the strategy of "integrated development of key intermediates-APIs-preparations" driven by R&D innovation and technological upgrading, develops characteristic API processes, and meets the growing basic medical and health needs of China with high quality and low price generic drugs; At the same time, deepen international cooperation and take the opportunity of international pharmaceutical giants to transfer production to establish a closer and longer-term cooperative relationship between CDMO and CMO. Seven. *ST Haiyi 600896
In terms of return on net assets, from 20 17 to 2020, it will be -34.24%, 6.62%,-10.45% and 3.65% respectively. The company takes "Blue Ocean Online" as the platform, and combines the offline medical resources of outpatient clinics to carry out Internet health consultation services.
Eight. Xinhua medical 600587
In terms of return on net assets, from 20 17 to 2020, it will be 2%, 0.69%, 23.54% and 5.47% respectively. The company has three business departments: medical devices, pharmaceutical equipment and medical services. Among them, medical devices are divided into medical device products, medical environmental protection equipment products and drugs and devices.
IX. Shanghai Pharmaceutical 60 1607
In terms of return on net assets, from 20 17 to 2020, it will be 10.73%, 10.34%, 10. 12% and 10.34% respectively. In terms of medical equipment business, the company's main products include ventilators, anesthetics, operating beds, sphygmomanometers (watches), surgical shadowless lamps, dentures, dental treatment machines and other products produced by Shanghai Medical Equipment Co., Ltd.